[The use of tumoral markers in clinical practice]

The characteristic of malignant tumor markers most frequently used in clinical practice is presented in the article. These markers include antigens (embryonal carcinoma, carbohydrate, prostate-specific, squamous cell carcinoma), alpha-fetoprotein, unspecific enolase. The algorithm for tumoral marker use and clinical interpretation of investigative results in patients with tumors of prostate and mammary gland, ovarian, cervical, endometrial, pulmonary and gastrointestinal carcinoma are presented.